Laboratory Corporation of America Holdings (NYSE:LH) Q1 2024 Earnings Call Transcript
Laboratory Corporation of America Holdings beats earnings expectations. Reported EPS is $3.68, expectations were $3.46.
Source: insidermonkey.com
Plasma Detect News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Plasma Detect. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Plasma Detect Today - Breaking & Trending Today
Labcorp Announces 2024 First Quarter Results
Updates Full-Year Guidance Results from Continuing Operations for first quarter 2024 versus last year:Revenue: $3.18 billion versus $3.04 billion or up 4.6% | Base Business grew 6.7%Diluted EPS:...
Source: marketscreener.com
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the strategic expansion of its precision oncology portfolio, solidifying its commitment to advancing cancer research and patient care on a global scale. The announcement underscores Labcorp's dedication to ...
Source: pharmiweb.com
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs
BURLINGTON - Labcorp , a global leader of innovative and comprehensive laboratory services, announced today the strategic expansion of its precision oncology portfolio, solidifying its commitment to...
Source: marketscreener.com
Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp® Plasma Detect™, the first clinically validated, tumor-informed, whole-genome sequencing circulating tumor DNA (ctDNA) molecular residual disease (MRD) solution in early stage colon cancer ...
Source: pharmiweb.com